MALAT1 and diabetes mellitus: In general, elevated levels of MALAT1 expression in various complications associated with diabetes mellitus, as well as therapeutic effects on MALAT1 with synthetic oligonucleotides and siRNAs, define MALAT1 as a therapeutic target and potential biomarker.